Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Acute Symptoms of Bipolar Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating aripiprazole for acute symptoms of Bipolar I Disorder has completed, sponsored by Otsuka.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED